Sotera Health (NASDAQ:SHC) is MIG Capital LLC’s Largest Position

MIG Capital LLC decreased its position in shares of Sotera Health (NASDAQ:SHC) by 2.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,918,577 shares of the company’s stock after selling 140,183 shares during the quarter. Sotera Health makes up 12.0% of MIG Capital LLC’s holdings, making the stock its largest holding. MIG Capital LLC owned about 2.09% of Sotera Health worth $98,840,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in SHC. MetLife Investment Management LLC increased its holdings in Sotera Health by 20.4% during the third quarter. MetLife Investment Management LLC now owns 79,003 shares of the company’s stock valued at $1,319,000 after buying an additional 13,399 shares during the period. Mudita Advisors LLP lifted its holdings in Sotera Health by 5.2% during the third quarter. Mudita Advisors LLP now owns 406,329 shares of the company’s stock worth $6,786,000 after buying an additional 20,000 shares during the period. FMR LLC boosted its position in Sotera Health by 259.9% during the 3rd quarter. FMR LLC now owns 32,483 shares of the company’s stock valued at $542,000 after acquiring an additional 23,457 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Sotera Health by 11.4% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 128,222 shares of the company’s stock valued at $2,141,000 after acquiring an additional 13,157 shares during the period. Finally, Cerity Partners LLC bought a new position in shares of Sotera Health in the 3rd quarter worth $1,489,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a report on Thursday, November 21st. Finally, Barclays boosted their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Sotera Health currently has an average rating of “Moderate Buy” and a consensus price target of $16.50.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $13.10 on Thursday. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The company has a market cap of $3.71 billion, a PE ratio of 52.40 and a beta of 2.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business has a 50-day simple moving average of $15.39 and a two-hundred day simple moving average of $14.00.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same quarter last year, the business earned $0.18 earnings per share. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. As a group, equities analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the sale, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This represents a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 55.12% of the stock is currently owned by company insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.